Essa Pharma Inc

NASDAQ : EPIX

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Information

Website
https://www.essapharma.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Canada

Price

USD 7.10

Symbol

EPIX

Type

Common Stock

Previous Close

 :

7.06

52 Week Range

 :

2.58 - 11.67

Volume

 :

45,400.00

Average Volume

 :

135,000.00

High

 :

7.10

Low

 :

6.73

Change

 :

0.04

Percent change (%)

 :

0.57

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...